| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |